Overview

Multiple Dose Study of TRx0037

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of TRx0037 after multiple doses in elderly volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
TauRx Therapeutics Ltd
Collaborator:
Quotient Clinical